Biovica International AB
(STU:9II)
€
0.208
-0.012 (-5.45%)
Market Cap: 21.30 Mil
Enterprise Value: 15.01 Mil
PE Ratio: 0
PB Ratio: 2.33
GF Score: 60/100 - Q2 2023 Biovica International AB Earnings Call TranscriptDec 15, 2022€0.742 (+1.50%)Earnings
- Biovica International AB Market update FDA clearance TranscriptAug 18, 2022
- Q4 2022 Biovica International AB Earnings Call TranscriptJun 16, 2022€3.15 (+2.75%)Earnings
- Biovica International AB Corporate Analyst Meeting TranscriptMay 17, 2022
- Q3 2022 Biovica International AB Earnings Call TranscriptMar 15, 2022€2.62 (+7.74%)Earnings
- Q2 2022 Biovica International AB Earnings Call TranscriptDec 01, 2021€3.68 (+0.95%)Earnings
- Q1 2022 Biovica International AB Earnings Call TranscriptSep 02, 2021€5.85 (+6.29%)Earnings
- Biovica International AB CEO's Presentation Annual General Meeting 2021 - Pre-Recorded TranscriptAug 27, 2021
- Q4 2021 Biovica International AB Earnings Call TranscriptJun 18, 2021€4.48 (-0.22%)Earnings
- Biovica International AB Capital Markets Day (Virtual) TranscriptJun 09, 2021
- Q3 2021 Biovica International AB Earnings Call TranscriptMar 18, 2021€4.05 (+7.63%)Earnings
- Q2 2021 Biovica International AB Earnings Call TranscriptDec 08, 2020Earnings
Q1 2022 Biovica International AB Earnings Call Transcript
Sep 02, 2021 / 08:00AM GMT
Release Date Price:
€5.85
(+6.29%)
Operator
Welcome to the Biovica International Audiocast Teleconference Q1 2021 to 2022. (Operator Instructions)
Today, I am pleased to present CEO, Anders Rylander; and CFO, Cecilia Driving. Please begin your meeting.
Anders Rylander;publ;CEO;Director
Biovica International AB
()-&
Thank you very much, and hello, everyone. If we move directly to Slide 2. My name is Anders Rylander, and together with me, I have...
Cecilia Driving;publ;CFO;Executive VP
Biovica International AB
()-&
Cecilia Driving.
Anders Rylander;publ;CEO;Director
Biovica International AB
()-&
And we are going to present our interim report for the first quarter as our fiscal year starts 1st of May.
And if we move to the next slide, we have the agenda. I will first go through just a short introduction to Biovica as a company and our business
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)